Exodus Point Capital Management, LP Forma Therapeutics Holdings, Inc. Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
SELL
$7.12 - $20.24 $77,173 - $219,381
-10,839 Closed
0 $0
Q2 2022

Aug 19, 2022
SELL
$5.1 - $10.0 $24,816 - $48,660
-4,866 Reduced 30.98%
10,839 $75,000
Q1 2022

May 13, 2022
BUY
$8.34 - $14.69 $34,544 - $60,845
4,142 Added 35.82%
15,705 $146,000
Q4 2021

Feb 11, 2022
SELL
$13.6 - $24.89 $145,030 - $265,426
-10,664 Reduced 47.98%
11,563 $164,000
Q3 2021

Nov 15, 2021
BUY
$21.22 - $25.7 $471,656 - $571,233
22,227 New
22,227 $515,000

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email